Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
44
MMSI Quote, Financials, Valuation and Earnings
Last price:
$98.05
Seasonality move
:
1.32%
Day range:
$96.64 - $98.33
52-week range:
$70.70 - $108.08
Dividend yield:
0%
P/E ratio:
47.61x
P/S ratio:
4.33x
P/B ratio:
4.30x
Volume:
324.3K
Avg. volume:
426.4K
1-year change:
29.13%
Market cap:
$5.7B
Revenue:
$1.3B
EPS (TTM):
$2.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems
|
$334.6M | $0.80 | 7.12% | 71.67% | $113.20 |
|
ABT
Abbott Laboratories
|
$10.6B | $1.20 | 7.79% | 47.49% | $130.20 |
|
BDX
Becton Dickinson &
|
$5.4B | $3.77 | 8.75% | 211.95% | -- |
|
BSX
Boston Scientific
|
$4B | $0.59 | 18.39% | 92.99% | $99.14 |
|
GMED
Globus Medical
|
$604.8M | $0.65 | 3.07% | 577.27% | $94.23 |
|
RMD
ResMed
|
$1.2B | $2.04 | 9.72% | 64.2% | $206.05 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems
|
$97.61 | $113.20 | $5.7B | 47.61x | $0.00 | 0% | 4.33x |
|
ABT
Abbott Laboratories
|
$114.31 | $130.20 | $198.3B | 34.74x | $0.55 | 1.93% | 4.85x |
|
BDX
Becton Dickinson &
|
$226.44 | -- | $65.5B | 38.12x | $1.04 | 1.72% | 3.26x |
|
BSX
Boston Scientific
|
$89.86 | $99.14 | $132.4B | 74.26x | $0.00 | 0% | 8.37x |
|
GMED
Globus Medical
|
$83.10 | $94.23 | $11.3B | 124.03x | $0.00 | 0% | 4.60x |
|
RMD
ResMed
|
$231.17 | $206.05 | $33.9B | 30.62x | $0.53 | 0.87% | 7.09x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MMSI
Merit Medical Systems
|
36.19% | 0.720 | 13.03% | 3.66x |
|
ABT
Abbott Laboratories
|
27.35% | 0.747 | 8.05% | 1.14x |
|
BDX
Becton Dickinson &
|
43.72% | 0.356 | 28.85% | 0.58x |
|
BSX
Boston Scientific
|
34.45% | 0.299 | 8.79% | 0.85x |
|
GMED
Globus Medical
|
9.7% | 2.476 | 4.5% | 1.57x |
|
RMD
ResMed
|
11.54% | -0.864 | 1.89% | 1.37x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems
|
$157.5M | $37.4M | 6.16% | 9.56% | 12.99% | $37.4M |
|
ABT
Abbott Laboratories
|
$5.9B | $1.9B | 10.69% | 14.78% | 19.58% | $2.1B |
|
BDX
Becton Dickinson &
|
$2.5B | $793M | 3.91% | 6.63% | 12.31% | $882M |
|
BSX
Boston Scientific
|
$2.9B | $718M | 5.95% | 8.91% | 17.77% | $698M |
|
GMED
Globus Medical
|
$355.2M | $49M | 2.05% | 2.27% | 7.83% | $161.7M |
|
RMD
ResMed
|
$717.2M | $387.3M | 19.59% | 23.76% | 31.63% | $305.9M |
Merit Medical Systems vs. Competitors
-
Which has Higher Returns MMSI or ABT?
Abbott Laboratories has a net margin of 8.37% compared to Merit Medical Systems's net margin of 15.48%. Merit Medical Systems's return on equity of 9.56% beat Abbott Laboratories's return on equity of 14.78%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems46.36% $0.48 $2.1B ABTAbbott Laboratories55.83% $0.94 $55B -
What do Analysts Say About MMSI or ABT?
Merit Medical Systems has a consensus price target of $113.20, signalling upside risk potential of 15.97%. On the other hand Abbott Laboratories has an analysts' consensus of $130.20 which suggests that it could grow by 13.91%. Given that Merit Medical Systems has higher upside potential than Abbott Laboratories, analysts believe Merit Medical Systems is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems5 1 0 ABTAbbott Laboratories13 5 0 -
Is MMSI or ABT More Risky?
Merit Medical Systems has a beta of 0.844, which suggesting that the stock is 15.557% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.271%.
-
Which is a Better Dividend Stock MMSI or ABT?
Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.93% to investors and pays a quarterly dividend of $0.55 per share. Merit Medical Systems pays -- of its earnings as a dividend. Abbott Laboratories pays out 62.14% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MMSI or ABT?
Merit Medical Systems quarterly revenues are $339.8M, which are smaller than Abbott Laboratories quarterly revenues of $10.6B. Merit Medical Systems's net income of $28.4M is lower than Abbott Laboratories's net income of $1.6B. Notably, Merit Medical Systems's price-to-earnings ratio is 47.61x while Abbott Laboratories's PE ratio is 34.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 4.85x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems4.33x 47.61x $339.8M $28.4M ABTAbbott Laboratories4.85x 34.74x $10.6B $1.6B
-
Which has Higher Returns MMSI or BDX?
Becton Dickinson & has a net margin of 8.37% compared to Merit Medical Systems's net margin of 7.36%. Merit Medical Systems's return on equity of 9.56% beat Becton Dickinson &'s return on equity of 6.63%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems46.36% $0.48 $2.1B BDXBecton Dickinson &45.74% $1.45 $46B -
What do Analysts Say About MMSI or BDX?
Merit Medical Systems has a consensus price target of $113.20, signalling upside risk potential of 15.97%. On the other hand Becton Dickinson & has an analysts' consensus of -- which suggests that it could grow by 23.67%. Given that Becton Dickinson & has higher upside potential than Merit Medical Systems, analysts believe Becton Dickinson & is more attractive than Merit Medical Systems.
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems5 1 0 BDXBecton Dickinson &0 0 0 -
Is MMSI or BDX More Risky?
Merit Medical Systems has a beta of 0.844, which suggesting that the stock is 15.557% less volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.216%.
-
Which is a Better Dividend Stock MMSI or BDX?
Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 1.72% to investors and pays a quarterly dividend of $1.04 per share. Merit Medical Systems pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MMSI or BDX?
Merit Medical Systems quarterly revenues are $339.8M, which are smaller than Becton Dickinson & quarterly revenues of $5.4B. Merit Medical Systems's net income of $28.4M is lower than Becton Dickinson &'s net income of $400M. Notably, Merit Medical Systems's price-to-earnings ratio is 47.61x while Becton Dickinson &'s PE ratio is 38.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 3.26x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems4.33x 47.61x $339.8M $28.4M BDXBecton Dickinson &3.26x 38.12x $5.4B $400M
-
Which has Higher Returns MMSI or BSX?
Boston Scientific has a net margin of 8.37% compared to Merit Medical Systems's net margin of 11.12%. Merit Medical Systems's return on equity of 9.56% beat Boston Scientific's return on equity of 8.91%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems46.36% $0.48 $2.1B BSXBoston Scientific68.83% $0.32 $31.8B -
What do Analysts Say About MMSI or BSX?
Merit Medical Systems has a consensus price target of $113.20, signalling upside risk potential of 15.97%. On the other hand Boston Scientific has an analysts' consensus of $99.14 which suggests that it could grow by 10.33%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems5 1 0 BSXBoston Scientific21 5 0 -
Is MMSI or BSX More Risky?
Merit Medical Systems has a beta of 0.844, which suggesting that the stock is 15.557% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.802, suggesting its less volatile than the S&P 500 by 19.799%.
-
Which is a Better Dividend Stock MMSI or BSX?
Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out 1.76% of its earnings as a dividend. Boston Scientific's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MMSI or BSX?
Merit Medical Systems quarterly revenues are $339.8M, which are smaller than Boston Scientific quarterly revenues of $4.2B. Merit Medical Systems's net income of $28.4M is lower than Boston Scientific's net income of $468M. Notably, Merit Medical Systems's price-to-earnings ratio is 47.61x while Boston Scientific's PE ratio is 74.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 8.37x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems4.33x 47.61x $339.8M $28.4M BSXBoston Scientific8.37x 74.26x $4.2B $468M
-
Which has Higher Returns MMSI or GMED?
Globus Medical has a net margin of 8.37% compared to Merit Medical Systems's net margin of 8.28%. Merit Medical Systems's return on equity of 9.56% beat Globus Medical's return on equity of 2.27%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems46.36% $0.48 $2.1B GMEDGlobus Medical56.77% $0.38 $4.5B -
What do Analysts Say About MMSI or GMED?
Merit Medical Systems has a consensus price target of $113.20, signalling upside risk potential of 15.97%. On the other hand Globus Medical has an analysts' consensus of $94.23 which suggests that it could grow by 13.39%. Given that Merit Medical Systems has higher upside potential than Globus Medical, analysts believe Merit Medical Systems is more attractive than Globus Medical.
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems5 1 0 GMEDGlobus Medical5 4 0 -
Is MMSI or GMED More Risky?
Merit Medical Systems has a beta of 0.844, which suggesting that the stock is 15.557% less volatile than S&P 500. In comparison Globus Medical has a beta of 1.190, suggesting its more volatile than the S&P 500 by 19.035%.
-
Which is a Better Dividend Stock MMSI or GMED?
Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or GMED?
Merit Medical Systems quarterly revenues are $339.8M, which are smaller than Globus Medical quarterly revenues of $625.7M. Merit Medical Systems's net income of $28.4M is lower than Globus Medical's net income of $51.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 47.61x while Globus Medical's PE ratio is 124.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 4.60x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems4.33x 47.61x $339.8M $28.4M GMEDGlobus Medical4.60x 124.03x $625.7M $51.8M
-
Which has Higher Returns MMSI or RMD?
ResMed has a net margin of 8.37% compared to Merit Medical Systems's net margin of 25.43%. Merit Medical Systems's return on equity of 9.56% beat ResMed's return on equity of 23.76%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems46.36% $0.48 $2.1B RMDResMed58.57% $2.11 $5.9B -
What do Analysts Say About MMSI or RMD?
Merit Medical Systems has a consensus price target of $113.20, signalling upside risk potential of 15.97%. On the other hand ResMed has an analysts' consensus of $206.05 which suggests that it could grow by 9.49%. Given that Merit Medical Systems has higher upside potential than ResMed, analysts believe Merit Medical Systems is more attractive than ResMed.
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems5 1 0 RMDResMed6 5 0 -
Is MMSI or RMD More Risky?
Merit Medical Systems has a beta of 0.844, which suggesting that the stock is 15.557% less volatile than S&P 500. In comparison ResMed has a beta of 0.684, suggesting its less volatile than the S&P 500 by 31.593%.
-
Which is a Better Dividend Stock MMSI or RMD?
Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.87% to investors and pays a quarterly dividend of $0.53 per share. Merit Medical Systems pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MMSI or RMD?
Merit Medical Systems quarterly revenues are $339.8M, which are smaller than ResMed quarterly revenues of $1.2B. Merit Medical Systems's net income of $28.4M is lower than ResMed's net income of $311.4M. Notably, Merit Medical Systems's price-to-earnings ratio is 47.61x while ResMed's PE ratio is 30.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 7.09x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems4.33x 47.61x $339.8M $28.4M RMDResMed7.09x 30.62x $1.2B $311.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
52
TSLL alert for Dec 24
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
31
SOXL alert for Dec 24
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.
